

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 7.93535550 |
| 2 | thrombin receptor signaling pathway (GO:0070493) | 7.53804124 |
| 3 | protein neddylation (GO:0045116) | 7.41936824 |
| 4 | regulation of platelet aggregation (GO:0090330) | 6.09823704 |
| 5 | adenosine receptor signaling pathway (GO:0001973) | 5.96685963 |
| 6 | regulation of platelet activation (GO:0010543) | 5.62699925 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.52778115 |
| 8 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.34996577 |
| 9 | platelet aggregation (GO:0070527) | 5.32097865 |
| 10 | blood coagulation, intrinsic pathway (GO:0007597) | 5.19202458 |
| 11 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.87254524 |
| 12 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.81953228 |
| 13 | lipoxygenase pathway (GO:0019372) | 4.81016890 |
| 14 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.71877289 |
| 15 | neutrophil activation (GO:0042119) | 4.68699504 |
| 16 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.59733735 |
| 17 | megakaryocyte development (GO:0035855) | 4.56665157 |
| 18 | negative regulation of norepinephrine secretion (GO:0010700) | 4.52597453 |
| 19 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.47526871 |
| 20 | negative regulation of platelet activation (GO:0010544) | 4.46245867 |
| 21 | positive regulation of mast cell activation (GO:0033005) | 4.44088855 |
| 22 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.30539596 |
| 23 | granulocyte activation (GO:0036230) | 4.24046604 |
| 24 | low-density lipoprotein particle remodeling (GO:0034374) | 4.18674100 |
| 25 | angiogenesis involved in wound healing (GO:0060055) | 4.03791391 |
| 26 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.02211472 |
| 27 | platelet formation (GO:0030220) | 4.00188640 |
| 28 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.00104036 |
| 29 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.93754399 |
| 30 | platelet degranulation (GO:0002576) | 3.93467748 |
| 31 | regulation of integrin activation (GO:0033623) | 3.92932476 |
| 32 | purinergic receptor signaling pathway (GO:0035587) | 3.85226848 |
| 33 | negative regulation of heart rate (GO:0010459) | 3.82156569 |
| 34 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.78906620 |
| 35 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.76313742 |
| 36 | homotypic cell-cell adhesion (GO:0034109) | 3.71673601 |
| 37 | positive regulation of macrophage differentiation (GO:0045651) | 3.70039009 |
| 38 | platelet activation (GO:0030168) | 3.69191442 |
| 39 | leukocyte degranulation (GO:0043299) | 3.66401822 |
| 40 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.62910650 |
| 41 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.53691193 |
| 42 | regulation of mast cell degranulation (GO:0043304) | 3.53526242 |
| 43 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.49932268 |
| 44 | negative regulation of appetite (GO:0032099) | 3.49393137 |
| 45 | negative regulation of response to food (GO:0032096) | 3.49393137 |
| 46 | positive regulation of receptor recycling (GO:0001921) | 3.49055383 |
| 47 | polyamine biosynthetic process (GO:0006596) | 3.43833151 |
| 48 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.42168334 |
| 49 | positive regulation of granulocyte differentiation (GO:0030854) | 3.38166232 |
| 50 | beta-amyloid metabolic process (GO:0050435) | 3.38097211 |
| 51 | regulation of lipoprotein metabolic process (GO:0050746) | 3.37033122 |
| 52 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.34978643 |
| 53 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.33177286 |
| 54 | negative regulation of T cell apoptotic process (GO:0070233) | 3.29933055 |
| 55 | high-density lipoprotein particle remodeling (GO:0034375) | 3.29776919 |
| 56 | regulation of mast cell activation (GO:0033003) | 3.27472354 |
| 57 | negative regulation of protein localization to cell surface (GO:2000009) | 3.27398715 |
| 58 | regulation of cholesterol efflux (GO:0010874) | 3.26405915 |
| 59 | autophagic vacuole fusion (GO:0000046) | 3.26247587 |
| 60 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.25707940 |
| 61 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.24641862 |
| 62 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.22233691 |
| 63 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.21281991 |
| 64 | positive regulation of blood coagulation (GO:0030194) | 3.19509219 |
| 65 | positive regulation of hemostasis (GO:1900048) | 3.19509219 |
| 66 | regulation of female receptivity (GO:0045924) | 3.19337127 |
| 67 | mitochondrial calcium ion transport (GO:0006851) | 3.18641205 |
| 68 | extracellular fibril organization (GO:0043206) | 3.15328931 |
| 69 | vesicle targeting (GO:0006903) | 3.12512224 |
| 70 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.11838459 |
| 71 | cyclooxygenase pathway (GO:0019371) | 3.09588870 |
| 72 | regulation of norepinephrine secretion (GO:0014061) | 3.08932058 |
| 73 | positive regulation of mast cell degranulation (GO:0043306) | 3.07842670 |
| 74 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.07842670 |
| 75 | reverse cholesterol transport (GO:0043691) | 3.05160672 |
| 76 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.03789621 |
| 77 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.03789621 |
| 78 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.97372908 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.94808992 |
| 80 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.94303053 |
| 81 | termination of signal transduction (GO:0023021) | 2.93678602 |
| 82 | female mating behavior (GO:0060180) | 2.92677322 |
| 83 | negative regulation of stress fiber assembly (GO:0051497) | 2.92311352 |
| 84 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.91933956 |
| 85 | negative regulation of heart contraction (GO:0045822) | 2.88989863 |
| 86 | endothelium development (GO:0003158) | 2.88536253 |
| 87 | peptide catabolic process (GO:0043171) | 2.88234611 |
| 88 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87935074 |
| 89 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.86675305 |
| 90 | myeloid cell activation involved in immune response (GO:0002275) | 2.85873039 |
| 91 | regulation of receptor recycling (GO:0001919) | 2.85287317 |
| 92 | phagocytosis, engulfment (GO:0006911) | 2.85277066 |
| 93 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.84119287 |
| 94 | regulation of regulatory T cell differentiation (GO:0045589) | 2.82941982 |
| 95 | positive regulation of coagulation (GO:0050820) | 2.82549096 |
| 96 | phospholipid homeostasis (GO:0055091) | 2.78116979 |
| 97 | regulation of memory T cell differentiation (GO:0043380) | 2.77616336 |
| 98 | myeloid cell development (GO:0061515) | 2.77390718 |
| 99 | cardiolipin metabolic process (GO:0032048) | 2.77354983 |
| 100 | regulation of megakaryocyte differentiation (GO:0045652) | 2.77081534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.71319523 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.69187511 |
| 3 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.34875650 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.96059288 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.77085952 |
| 6 | GATA1_19941826_ChIP-Seq_K562_Human | 3.55427304 |
| 7 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.16050808 |
| 8 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 3.08112561 |
| 9 | GATA2_19941826_ChIP-Seq_K562_Human | 2.84576853 |
| 10 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.84103629 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.80090693 |
| 12 | SPI1_23127762_ChIP-Seq_K562_Human | 2.76099217 |
| 13 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.68095231 |
| 14 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.63844953 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59128152 |
| 16 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.58024912 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.57489350 |
| 18 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.49169294 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.42899366 |
| 20 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42036473 |
| 21 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.41959598 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.37195525 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.30672681 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.25795529 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16720441 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03937972 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.02850750 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.96787865 |
| 29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.91114462 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.87935955 |
| 31 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.87095389 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79835983 |
| 33 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.78573756 |
| 34 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.77337111 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71948498 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.70578395 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65161364 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65159297 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63760055 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62242234 |
| 41 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.60478489 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55618784 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54344916 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53358738 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.48289871 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46719062 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43681508 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.41472488 |
| 49 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.39788007 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.34570350 |
| 51 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.30812539 |
| 52 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.30432441 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28884213 |
| 54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28803454 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.28221011 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27858693 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26750448 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.26562300 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25955609 |
| 60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16832633 |
| 61 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15504065 |
| 62 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13826808 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11796717 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.11001055 |
| 65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09698909 |
| 66 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.09105870 |
| 67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08556453 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08377785 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07861567 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07337103 |
| 71 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.07221955 |
| 72 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06605450 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06296672 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05999914 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04840891 |
| 76 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04095923 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03137714 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01626598 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01474197 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01195422 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99303532 |
| 82 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97739004 |
| 83 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.97603315 |
| 84 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96630101 |
| 85 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96479199 |
| 86 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.93036047 |
| 87 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90844591 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89457820 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89291995 |
| 90 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.89253673 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89242733 |
| 92 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88703862 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87227737 |
| 94 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.86565394 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.85502397 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84038826 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81109552 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80435963 |
| 99 | * MAF_26560356_Chip-Seq_TH2_Human | 0.78351154 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.78164378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 9.46428241 |
| 2 | MP0008004_abnormal_stomach_pH | 5.03725787 |
| 3 | MP0003724_increased_susceptibility_to | 3.55824036 |
| 4 | MP0000465_gastrointestinal_hemorrhage | 3.29165695 |
| 5 | MP0003303_peritoneal_inflammation | 3.18737350 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.59791932 |
| 7 | MP0005083_abnormal_biliary_tract | 2.43835077 |
| 8 | MP0004510_myositis | 2.27853284 |
| 9 | MP0000343_altered_response_to | 2.17327630 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.13903483 |
| 11 | MP0005084_abnormal_gallbladder_morpholo | 2.11461750 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.09362333 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.09362333 |
| 14 | MP0003436_decreased_susceptibility_to | 1.88522447 |
| 15 | MP0003566_abnormal_cell_adhesion | 1.86374968 |
| 16 | MP0010155_abnormal_intestine_physiology | 1.83820830 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 1.78987813 |
| 18 | MP0002398_abnormal_bone_marrow | 1.78881273 |
| 19 | MP0000230_abnormal_systemic_arterial | 1.77039282 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.73618403 |
| 21 | MP0003828_pulmonary_edema | 1.71516999 |
| 22 | MP0005671_abnormal_response_to | 1.71275579 |
| 23 | MP0002736_abnormal_nociception_after | 1.65775580 |
| 24 | MP0002132_abnormal_respiratory_system | 1.65003560 |
| 25 | MP0005410_abnormal_fertilization | 1.59993679 |
| 26 | MP0001851_eye_inflammation | 1.57485781 |
| 27 | MP0009278_abnormal_bone_marrow | 1.53815502 |
| 28 | MP0004947_skin_inflammation | 1.48583201 |
| 29 | MP0003638_abnormal_response/metabolism_ | 1.48196995 |
| 30 | MP0001879_abnormal_lymphatic_vessel | 1.45770544 |
| 31 | MP0002723_abnormal_immune_serum | 1.41640431 |
| 32 | MP0001663_abnormal_digestive_system | 1.41155010 |
| 33 | MP0004130_abnormal_muscle_cell | 1.39992466 |
| 34 | MP0000015_abnormal_ear_pigmentation | 1.36481876 |
| 35 | MP0004084_abnormal_cardiac_muscle | 1.33226848 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.33183845 |
| 37 | MP0001800_abnormal_humoral_immune | 1.32508950 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.31396526 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.31272545 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.31072927 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.30009278 |
| 42 | MP0008872_abnormal_physiological_respon | 1.29646619 |
| 43 | MP0002429_abnormal_blood_cell | 1.29312584 |
| 44 | MP0000858_altered_metastatic_potential | 1.26308123 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.25840754 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.23704443 |
| 47 | MP0002722_abnormal_immune_system | 1.23441008 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.23167718 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.22527963 |
| 50 | MP0001819_abnormal_immune_cell | 1.21697064 |
| 51 | MP0002419_abnormal_innate_immunity | 1.20550182 |
| 52 | MP0000249_abnormal_blood_vessel | 1.17750152 |
| 53 | MP0008775_abnormal_heart_ventricle | 1.16687932 |
| 54 | MP0005409_darkened_coat_color | 1.16560247 |
| 55 | MP0000716_abnormal_immune_system | 1.13770810 |
| 56 | MP0005025_abnormal_response_to | 1.10985078 |
| 57 | MP0003879_abnormal_hair_cell | 1.10669379 |
| 58 | MP0009763_increased_sensitivity_to | 1.09593851 |
| 59 | MP0004036_abnormal_muscle_relaxation | 1.06678625 |
| 60 | MP0003866_abnormal_defecation | 1.05754898 |
| 61 | MP0000490_abnormal_crypts_of | 1.04117171 |
| 62 | MP0000685_abnormal_immune_system | 1.03160448 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.01434414 |
| 64 | MP0010329_abnormal_lipoprotein_level | 0.99757456 |
| 65 | MP0003300_gastrointestinal_ulcer | 0.99206444 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 0.99061305 |
| 67 | MP0003763_abnormal_thymus_physiology | 0.98497807 |
| 68 | MP0001790_abnormal_immune_system | 0.96892520 |
| 69 | MP0005387_immune_system_phenotype | 0.96892520 |
| 70 | MP0009764_decreased_sensitivity_to | 0.96711882 |
| 71 | MP0005666_abnormal_adipose_tissue | 0.94235733 |
| 72 | MP0000703_abnormal_thymus_morphology | 0.93675178 |
| 73 | MP0008874_decreased_physiological_sensi | 0.91957477 |
| 74 | MP0002733_abnormal_thermal_nociception | 0.91955155 |
| 75 | MP0009642_abnormal_blood_homeostasis | 0.91719411 |
| 76 | MP0009697_abnormal_copulation | 0.90093111 |
| 77 | MP0008260_abnormal_autophagy | 0.87876848 |
| 78 | MP0005381_digestive/alimentary_phenotyp | 0.86899915 |
| 79 | MP0001664_abnormal_digestion | 0.86668156 |
| 80 | MP0005646_abnormal_pituitary_gland | 0.84305744 |
| 81 | MP0003136_yellow_coat_color | 0.83726359 |
| 82 | MP0005501_abnormal_skin_physiology | 0.83205162 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.82430338 |
| 84 | MP0001765_abnormal_ion_homeostasis | 0.82062582 |
| 85 | MP0002998_abnormal_bone_remodeling | 0.81151317 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 0.80615343 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.79911689 |
| 88 | MP0005023_abnormal_wound_healing | 0.75089332 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.74985568 |
| 90 | MP0002405_respiratory_system_inflammati | 0.73004822 |
| 91 | MP0000358_abnormal_cell_content/ | 0.69834223 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.68766046 |
| 93 | MP0003172_abnormal_lysosome_physiology | 0.67909992 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.67471091 |
| 95 | MP0002128_abnormal_blood_circulation | 0.66841915 |
| 96 | MP0004215_abnormal_myocardial_fiber | 0.66489160 |
| 97 | MP0003075_altered_response_to | 0.65642082 |
| 98 | MP0005171_absent_coat_pigmentation | 0.65610912 |
| 99 | MP0002877_abnormal_melanocyte_morpholog | 0.65102619 |
| 100 | MP0010368_abnormal_lymphatic_system | 0.63913933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.79696765 |
| 2 | Petechiae (HP:0000967) | 9.51549867 |
| 3 | Abnormal platelet volume (HP:0011876) | 9.38543305 |
| 4 | Purpura (HP:0000979) | 8.52834074 |
| 5 | Epistaxis (HP:0000421) | 7.86240196 |
| 6 | Gingival bleeding (HP:0000225) | 6.44472643 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 6.06181193 |
| 8 | Impaired platelet aggregation (HP:0003540) | 5.68934257 |
| 9 | Abnormal platelet function (HP:0011869) | 5.68934257 |
| 10 | Dyschromatopsia (HP:0007641) | 4.81989186 |
| 11 | Spontaneous hematomas (HP:0007420) | 4.39327096 |
| 12 | Acanthocytosis (HP:0001927) | 4.38444964 |
| 13 | Poikilocytosis (HP:0004447) | 4.38437656 |
| 14 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.78963087 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 3.74754263 |
| 16 | Conjunctival telangiectasia (HP:0000524) | 3.58057225 |
| 17 | Abnormal pupillary function (HP:0007686) | 3.46710393 |
| 18 | Bruising susceptibility (HP:0000978) | 3.45537794 |
| 19 | Paralysis (HP:0003470) | 3.36509671 |
| 20 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.21202027 |
| 21 | Abnormality of lateral ventricle (HP:0030047) | 3.12705373 |
| 22 | Abnormality of macrophages (HP:0004311) | 2.94628544 |
| 23 | Joint hemorrhage (HP:0005261) | 2.87437128 |
| 24 | Hepatosplenomegaly (HP:0001433) | 2.87266234 |
| 25 | Increased IgM level (HP:0003496) | 2.72675749 |
| 26 | Joint swelling (HP:0001386) | 2.56649927 |
| 27 | Increased density of long bones (HP:0006392) | 2.51453529 |
| 28 | Decreased central vision (HP:0007663) | 2.50680759 |
| 29 | Abnormality of iron homeostasis (HP:0011031) | 2.50040004 |
| 30 | Stomatitis (HP:0010280) | 2.50033064 |
| 31 | Male infertility (HP:0003251) | 2.49356093 |
| 32 | Xanthomatosis (HP:0000991) | 2.48022591 |
| 33 | Upper limb muscle weakness (HP:0003484) | 2.46050499 |
| 34 | Abnormal auditory evoked potentials (HP:0006958) | 2.30894392 |
| 35 | Obstructive lung disease (HP:0006536) | 2.30144267 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.30144267 |
| 37 | Tinnitus (HP:0000360) | 2.24333998 |
| 38 | Spontaneous abortion (HP:0005268) | 2.23292855 |
| 39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.23069351 |
| 40 | Encephalitis (HP:0002383) | 2.21233865 |
| 41 | Polycythemia (HP:0001901) | 2.19291423 |
| 42 | Papillary thyroid carcinoma (HP:0002895) | 2.12580677 |
| 43 | Increased serum ferritin (HP:0003281) | 2.11846296 |
| 44 | Dysautonomia (HP:0002459) | 2.10046722 |
| 45 | Hyperthyroidism (HP:0000836) | 2.07712684 |
| 46 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.07225459 |
| 47 | Eczematoid dermatitis (HP:0000976) | 2.05426605 |
| 48 | Episodic fever (HP:0001954) | 2.04941934 |
| 49 | Nausea (HP:0002018) | 2.02707721 |
| 50 | Arterial thrombosis (HP:0004420) | 2.00401507 |
| 51 | Prolonged bleeding time (HP:0003010) | 11.5285145 |
| 52 | Menorrhagia (HP:0000132) | 10.0820701 |
| 53 | Hypophosphatemic rickets (HP:0004912) | 1.95990365 |
| 54 | Autoimmune hemolytic anemia (HP:0001890) | 1.95167876 |
| 55 | Generalized aminoaciduria (HP:0002909) | 1.91376925 |
| 56 | Myocardial infarction (HP:0001658) | 1.88481661 |
| 57 | Thrombocytosis (HP:0001894) | 1.80167354 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.78344432 |
| 59 | Ventricular fibrillation (HP:0001663) | 1.77507580 |
| 60 | Hypertriglyceridemia (HP:0002155) | 1.74677261 |
| 61 | Dysostosis multiplex (HP:0000943) | 1.74126547 |
| 62 | Distal lower limb amyotrophy (HP:0008944) | 1.67495196 |
| 63 | Hemorrhage of the eye (HP:0011885) | 1.67485043 |
| 64 | Ileus (HP:0002595) | 1.65129995 |
| 65 | Basal ganglia calcification (HP:0002135) | 1.63703444 |
| 66 | Vertigo (HP:0002321) | 1.63211738 |
| 67 | Biliary tract neoplasm (HP:0100574) | 1.61318199 |
| 68 | Thyroid-stimulating hormone excess (HP:0002925) | 1.59184409 |
| 69 | Abnormality of the prostate (HP:0008775) | 1.57284005 |
| 70 | Recurrent abscess formation (HP:0002722) | 1.56822851 |
| 71 | Thrombophlebitis (HP:0004418) | 1.56701247 |
| 72 | 3-Methylglutaconic aciduria (HP:0003535) | 1.56240586 |
| 73 | Acute hepatic failure (HP:0006554) | 1.55241626 |
| 74 | Chest pain (HP:0100749) | 1.55164557 |
| 75 | Tongue fasciculations (HP:0001308) | 1.53641554 |
| 76 | Abnormal hemoglobin (HP:0011902) | 1.53631011 |
| 77 | Granulocytopenia (HP:0001913) | 1.51722798 |
| 78 | Muscle fibrillation (HP:0010546) | 1.50861016 |
| 79 | Renal Fanconi syndrome (HP:0001994) | 1.49624174 |
| 80 | Inflammation of the large intestine (HP:0002037) | 1.48856859 |
| 81 | Microcytic anemia (HP:0001935) | 1.48055799 |
| 82 | Exertional dyspnea (HP:0002875) | 1.44089985 |
| 83 | Abnormal ciliary motility (HP:0012262) | 1.43159211 |
| 84 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.43144038 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 1.43108415 |
| 86 | Testicular neoplasm (HP:0010788) | 1.42885684 |
| 87 | Abnormality of the Achilles tendon (HP:0005109) | 1.42217593 |
| 88 | Panhypogammaglobulinemia (HP:0003139) | 1.41603678 |
| 89 | Uterine leiomyosarcoma (HP:0002891) | 1.41454701 |
| 90 | Leiomyosarcoma (HP:0100243) | 1.41454701 |
| 91 | Gastrointestinal dysmotility (HP:0002579) | 1.40657107 |
| 92 | Central scotoma (HP:0000603) | 1.39251339 |
| 93 | Leukocytosis (HP:0001974) | 1.37558093 |
| 94 | Cerebral ischemia (HP:0002637) | 1.37461701 |
| 95 | Mucosal telangiectasiae (HP:0100579) | 1.37116337 |
| 96 | Infertility (HP:0000789) | 1.36655707 |
| 97 | Thyroid carcinoma (HP:0002890) | 1.35930740 |
| 98 | Back pain (HP:0003418) | 1.35309009 |
| 99 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.32950445 |
| 100 | Recurrent bacterial skin infections (HP:0005406) | 1.32213010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.61787676 |
| 2 | MST4 | 4.43775877 |
| 3 | BMX | 4.37653318 |
| 4 | BTK | 3.25830804 |
| 5 | MYLK | 3.20022452 |
| 6 | TEC | 3.19699667 |
| 7 | EIF2AK1 | 2.97170311 |
| 8 | PTK2B | 2.66126946 |
| 9 | CSF1R | 2.45059872 |
| 10 | ZAP70 | 2.40680311 |
| 11 | SYK | 2.37159396 |
| 12 | GRK6 | 2.24639500 |
| 13 | TAOK3 | 2.18564177 |
| 14 | PIK3CG | 2.00131707 |
| 15 | MAP2K3 | 1.97858745 |
| 16 | BMPR2 | 1.93826143 |
| 17 | ILK | 1.91021322 |
| 18 | FGR | 1.80908406 |
| 19 | BLK | 1.79156915 |
| 20 | GRK5 | 1.72480804 |
| 21 | TNK2 | 1.63109238 |
| 22 | HCK | 1.60277813 |
| 23 | FES | 1.56388972 |
| 24 | STK3 | 1.53094351 |
| 25 | ACVR1B | 1.45634594 |
| 26 | TESK2 | 1.31253331 |
| 27 | MATK | 1.31005961 |
| 28 | LYN | 1.26945421 |
| 29 | MARK3 | 1.24335141 |
| 30 | PAK1 | 1.21663904 |
| 31 | IKBKB | 1.19196633 |
| 32 | TAOK2 | 1.18607768 |
| 33 | MAP4K1 | 1.18103384 |
| 34 | MAPKAPK3 | 1.17293226 |
| 35 | DAPK3 | 1.03312425 |
| 36 | ITK | 0.96804002 |
| 37 | PIM2 | 0.93916975 |
| 38 | RET | 0.93594005 |
| 39 | CSK | 0.93517583 |
| 40 | SIK3 | 0.92242753 |
| 41 | MAP3K11 | 0.91335007 |
| 42 | TXK | 0.91207633 |
| 43 | LMTK2 | 0.89391273 |
| 44 | ADRBK2 | 0.88239266 |
| 45 | MAP3K5 | 0.87068506 |
| 46 | IRAK1 | 0.82714941 |
| 47 | IRAK3 | 0.81780189 |
| 48 | NUAK1 | 0.77291329 |
| 49 | PDPK1 | 0.76467899 |
| 50 | PDK1 | 0.73314451 |
| 51 | PRKD1 | 0.72918108 |
| 52 | PLK2 | 0.71069206 |
| 53 | JAK3 | 0.70830034 |
| 54 | STK24 | 0.70053460 |
| 55 | PNCK | 0.67954175 |
| 56 | IRAK4 | 0.66779668 |
| 57 | MAPK12 | 0.64828429 |
| 58 | TLK1 | 0.64772625 |
| 59 | ADRBK1 | 0.63839181 |
| 60 | LCK | 0.63684779 |
| 61 | DAPK2 | 0.62688126 |
| 62 | MAP3K3 | 0.62612239 |
| 63 | PKN1 | 0.58567244 |
| 64 | IRAK2 | 0.58278834 |
| 65 | MAP2K1 | 0.56330783 |
| 66 | BRSK2 | 0.54174821 |
| 67 | MAP3K1 | 0.53130513 |
| 68 | STK4 | 0.50595193 |
| 69 | TAOK1 | 0.50379964 |
| 70 | TNIK | 0.48993327 |
| 71 | ERBB2 | 0.46871431 |
| 72 | DAPK1 | 0.42574649 |
| 73 | FYN | 0.41874815 |
| 74 | JAK2 | 0.41177524 |
| 75 | PRKACG | 0.41167678 |
| 76 | PRKCQ | 0.37088187 |
| 77 | EPHB2 | 0.36989304 |
| 78 | DYRK3 | 0.36502021 |
| 79 | PDGFRB | 0.35877705 |
| 80 | DYRK1B | 0.34839512 |
| 81 | MAP4K2 | 0.30998109 |
| 82 | PRKCD | 0.30446553 |
| 83 | PIM1 | 0.30396944 |
| 84 | YES1 | 0.29130326 |
| 85 | EPHB1 | 0.28740487 |
| 86 | ZAK | 0.28408887 |
| 87 | ARAF | 0.26711050 |
| 88 | SIK1 | 0.24990988 |
| 89 | MAPK11 | 0.24644900 |
| 90 | PRKG1 | 0.24226885 |
| 91 | RAF1 | 0.24031945 |
| 92 | FER | 0.24003280 |
| 93 | PRPF4B | 0.22580228 |
| 94 | FLT3 | 0.21744320 |
| 95 | CDK14 | 0.21414924 |
| 96 | HIPK2 | 0.21091170 |
| 97 | PRKCB | 0.21074229 |
| 98 | SRC | 0.20469329 |
| 99 | MAPKAPK2 | 0.19933741 |
| 100 | EPHA3 | 0.19560210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 5.64603833 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.32483249 |
| 3 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 3.22134376 |
| 4 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.56855783 |
| 5 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.53874390 |
| 6 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.07313174 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.89149806 |
| 8 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.88296206 |
| 9 | Gap junction_Homo sapiens_hsa04540 | 1.77841992 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68884675 |
| 11 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.56666685 |
| 12 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.53525946 |
| 13 | Shigellosis_Homo sapiens_hsa05131 | 1.47403053 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44444142 |
| 15 | Endocytosis_Homo sapiens_hsa04144 | 1.40208584 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.36973144 |
| 17 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.36268150 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34323917 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33268647 |
| 20 | Alcoholism_Homo sapiens_hsa05034 | 1.32753225 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23443419 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.22705239 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.17463161 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13518924 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.12187945 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.11896925 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11188532 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.10388444 |
| 29 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.09944953 |
| 30 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.09611018 |
| 31 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07018426 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06748727 |
| 33 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06629994 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03750465 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02943926 |
| 36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02680185 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98873964 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96686285 |
| 39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92442351 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92308475 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.90264010 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 0.89404663 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87200701 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81695916 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81637475 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81211571 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81188192 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81010637 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 0.77684243 |
| 50 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77255017 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75324999 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75030403 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 0.74984594 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74726995 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73264053 |
| 56 | Focal adhesion_Homo sapiens_hsa04510 | 0.73072763 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72796638 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72728167 |
| 59 | Asthma_Homo sapiens_hsa05310 | 0.69149861 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68918933 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68657597 |
| 62 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68221965 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65578721 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65151761 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63616965 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.62957739 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 0.60913037 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.60215635 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59791997 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59109158 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59060313 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58168462 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57235291 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57212744 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56825035 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.56155713 |
| 77 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55678990 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55553153 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.53374997 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53207716 |
| 81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50900510 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50004571 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49216500 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49213057 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48048372 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46973347 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46453823 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46198422 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46013787 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.45565092 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44926758 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.44008411 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42812803 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42156403 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41917374 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41593527 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.39408654 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39153651 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38440158 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.37981367 |

